Published science.
Purposeful development.
We connect fundamental biology, therapeutic design and preclinical evaluation. Our founders’ research spans drug delivery, nanomedicine, immunotherapy, biomaterials and the microbiome—experience we bring to the questions our partners need to answer.
The papers below come from our founders’ academic and collaborative research, including work published before Elpida BioPharm was established. Each entry identifies the participating founder(s) and links to the original publication, where the full author list, affiliations, methods and findings can be examined.
Experience built around scientific questions
Our core strengths intersect across therapeutic areas and product types. The question and the evidence required guide the study.
Drug delivery & nanomedicine
Formulation, gene and small-molecule delivery, pharmacokinetics, biodistribution and long-term nanoparticle fate.
Explore a relevant publicationRNA therapeutics & immunotherapy
mRNA nanomedicine, cancer vaccines and immune modulation, connecting delivery mechanisms with disease-relevant endpoints.
Explore a relevant publicationMicrobiome & bacterial therapeutics
Microbial ecology, probiotic behaviour and mathematical frameworks that help turn an ecological hypothesis into a testable programme.
Explore a relevant publicationBiomaterials & cell biology
Drug-releasing materials, medical-device prototypes, nanoparticle–cell interactions and molecular responses in cellular systems.
Explore a relevant publicationExperimental pharmacology & safety
Disease-model experience, tissue injury, microcirculation and nanomaterial biocompatibility across complementary readouts.
Explore a relevant publicationAntimicrobial research
Drug-resistant bacteria, biofilms and nanotechnology-based treatment strategies, informed by our published analysis of the field.
Explore a relevant publicationFrom scientific idea to published evidence
Selected studies in drug delivery, nanomedicine and preclinical research.
mRNA delivery and tumour immunity
IL-10 mRNA delivery to modulate antitumour immunity.
View publication details
Targeted delivery to lung metastases
Erythrocyte-assisted delivery in a melanoma lung-metastasis model.
View publication details
Drug-releasing contact lens
Drug release and preclinical evaluation of a contact-lens prototype.
View publication details
Nanoparticle pharmacokinetics
Early nanoparticle clearance and detailed blood-circulation kinetics.
View publication details
Long-term nanoparticle fate
Nanoparticle distribution, persistence and degradation tracked in mice.
View publication details
Gene and small-molecule delivery
MOF carriers for combined gene and small-molecule delivery.
View publication details
Modelling probiotic behaviour
A proposed mathematical framework for probiotic behaviour in the gut.
View publication details
Ischaemia–reperfusion research
Nicotinamide riboside in a rat intestinal ischaemia–reperfusion model.
View publication detailsExplore the original publications for the full scientific context, methods, results and author contributions.
From nanoparticles to gene-expression responses
Explore the Acta Biomaterialia studyIn a collaborative study, magnetic nanoparticles were used to investigate mechanical signalling in human mesenchymal stem cells, with RNA sequencing and bioinformatics connecting cellular stimulation to gene-expression responses.
The work illustrates how material–cell interactions can be examined beyond uptake alone. Both Alexey Yaremenko and Nadezhda Pechnikova are authors and list Elpida BioPharm among their affiliations.
Explore the research
38 selected publications from our founders’ research, rather than a complete bibliography. Open an entry for the study context and a link to the original paper.
2026Why probiotics fail: gut niche tension as the missing variable?Founders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
Introduces the Niche Tension Index, a proposed quantitative framework for the balance between ecological exclusion and facilitation in the gut.
Relevance to research design: Structures hypotheses for probiotic selection and experimental validation.
Microbial ecology · probiotics · mathematical modelling
The framework provides a basis for prospective experimental validation.
Read the publication · DOI 10.1080/19490976.2026.27283332026A magnetogenetic atlas of cytoskeleton-resolved gene regulation in mesenchymal stem cellsFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
An experimental study using magnetic nanoparticles and RNA sequencing to investigate how mechanical cues regulate gene expression in human mesenchymal stem cells.
Relevance to research design: Connects nanoparticle–cell interactions, mechanobiology and molecular readouts.
Stem cells · RNA sequencing · bioinformatics · mechanotransduction
Both founders list Elpida BioPharm among their affiliations.
Read the publication · DOI 10.1016/j.actbio.2026.02.0132026mRNA technology for the prevention and treatment of HIV-1 infectionFounders among the authors: Alexey V. Yaremenko
Examines mRNA platforms, delivery systems and emerging clinical evidence for HIV-1 prevention and treatment.
Relevance to research design: Brings delivery barriers, immune mechanisms and translational requirements into one development perspective.
mRNA platforms · vaccines · infectious disease · translation
Read the publication · DOI 10.1038/s44222-025-00387-22026Nanotechnology-based strategies for ROS-mediated anticancer and antimicrobial therapiesFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
A synthesis of nanotechnology-based approaches that use reactive oxygen species in anticancer and antimicrobial therapy.
Relevance to research design: Examines the relationship between material design, biological activity and safety questions.
Reactive oxygen species · cancer · infection · nanomedicine
Read the publication · DOI 10.1016/j.jconrel.2026.1149222026Engineered Nanoparticles for Combating Drug-Resistant Bacteria and Bacterial BiofilmsFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
Examines engineered nanoparticles for antimicrobial delivery and biofilm-directed treatment strategies.
Relevance to research design: Connects antimicrobial activity with biological barriers, biocompatibility and translational challenges.
Antimicrobial resistance · biofilms · nanomaterials
2026 journal issue; first published online in December 2025.
Read the publication · DOI 10.1021/acsnanomed.5c000602026mRNA vaccines for HBV: Mechanisms, preclinical advances, and therapeutic clinical progressFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
Links mRNA vaccine design and delivery with immune responses, preclinical evidence and therapeutic clinical development in hepatitis B.
Relevance to research design: Supports a critical assessment of how experimental endpoints relate to translational objectives.
mRNA vaccines · lipid nanoparticles · immune responses
2026 journal issue; first published online in December 2025.
Read the publication · DOI 10.1016/j.omtn.2025.1028192026Nanobiotechnology-Based Approaches for Uveal Melanoma TreatmentFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
Connects ocular drug delivery, nanomedicine and tumour immunology with the preclinical and translational challenges of treating uveal melanoma.
Relevance to research design: Integrates the biology of an ocular cancer with delivery barriers and therapeutic development.
Uveal melanoma · ocular delivery · tumour immunity
Read the publication · DOI 10.1002/smm2.700652025Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticlesFounders among the authors: Alexey V. Yaremenko
A collaborative preclinical study investigating how IL-10 delivered as mRNA nanoparticles can alter antitumour immune responses.
Relevance to research design: Connects delivery-system design with immune mechanisms and therapeutic evaluation.
mRNA nanomedicine · tumour models · immune responses
Read the publication · DOI 10.1038/s41565-025-01980-72025Advancing Lung Cancer Treatment: mRNA Therapeutics and Delivery StrategiesFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
Explores mRNA approaches for lung cancer, including therapeutic concepts, delivery barriers and nanocarrier design.
Relevance to research design: Helps frame the evidence needed to move a delivery concept towards a disease-focused programme.
Lung cancer · mRNA therapeutics · delivery strategies
Read the publication · DOI 10.1021/acs.nanolett.5c038262025Implantable Biomaterials for Cancer ImmunotherapiesFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
Examines implantable materials for local and sustained immune modulation within the tumour microenvironment.
Relevance to research design: Connects biomaterial properties, therapeutic release and immunological objectives.
Implantable devices · sustained release · cancer immunotherapy
Read the publication · DOI 10.1002/adfm.2024168132025Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumorsFounders among the authors: Alexey V. Yaremenko
An analysis of how intravital microscopy reveals nanoparticle transport and delivery within tumours.
Relevance to research design: Supports the interpretation of spatial distribution, biological barriers and heterogeneous delivery.
Intravital microscopy · tumour transport · biodistribution
Read the publication · DOI 10.1016/j.addr.2025.1155502025Clinical advances of mRNA vaccines for cancer immunotherapyFounders among the authors: Alexey V. Yaremenko
Assesses clinical progress in cancer mRNA vaccination and the challenges of advancing new immunotherapies.
Relevance to research design: Places preclinical objectives in the context of clinical questions and trial evidence.
Cancer vaccines · mRNA · clinical evidence assessment
Read the publication · DOI 10.1016/j.medj.2024.11.0152025Carbon Quantum Dots in Biomedical Applications: Advances, Challenges, and Future ProspectsFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
Examines carbon quantum dots for biomedical delivery, imaging and therapy, including material properties and biological safety.
Relevance to research design: Highlights the importance of material consistency, characterisation and application-specific evaluation.
Carbon nanomaterials · bioimaging · drug and gene delivery
Read the publication · DOI 10.1002/agt2.7072025Applications of Modern Cell Therapies: The Latest Data in OphthalmologyFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
Examines cell sources, biomaterial scaffolds and ocular delivery strategies alongside safety, potency and clinical translation in regenerative ophthalmology.
Relevance to research design: Connects cell-based product design with functional outcomes and development requirements.
Cell therapies · regenerative medicine · ophthalmology
Read the publication · DOI 10.3390/life151016102025Pre-Clinical and Clinical Advances in Gene Therapy of X-Linked Retinitis Pigmentosa: Hope on the HorizonFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
Links inherited retinal disease biology with gene-delivery platforms, preclinical development and the clinical progress of targeted gene therapies.
Relevance to research design: Relates genetic mechanisms and delivery strategies to disease-specific evaluation.
Gene therapy · inherited disease · retinal delivery
Read the publication · DOI 10.3390/jcm140308982024Modification of contact lenses via metal-organic frameworks for glaucoma treatmentFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
An experimental study connecting contact-lens modification, drug release and preclinical evaluation for an ocular delivery application.
Relevance to research design: Links a material-based prototype with measurable biological and functional performance.
Biomaterials · drug release · ocular delivery
Read the publication · DOI 10.1002/agt2.5862024Magnetogenetics as a promising tool for controlling cellular signaling pathwaysFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
Explores magnetic approaches to controlling cellular signalling, spanning mechanotransduction and regenerative applications.
Relevance to research design: Frames testable questions about how nanoparticles influence cellular behaviour.
Magnetic nanoparticles · cell signalling · mechanobiology
Read the publication · DOI 10.1186/s12951-024-02616-z2024Association of Fetal Lung Development Disorders with Adult Diseases: A Comprehensive ReviewFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
Connects disturbances in fetal lung development with adult respiratory disease, examining biological mechanisms and implications for prevention and future research.
Relevance to research design: Links developmental biology with later disease susceptibility and translational questions.
Respiratory biology · developmental origins of disease
Read the publication · DOI 10.3390/jpm140403682024Expression patterns and clinical implications of PDL1 and DLL3 biomarkers in small cell lung cancer retrospectively studied: Insights for therapeutic strategies and survival predictionFounders among the authors: Alexey V. Yaremenko
A retrospective study of patient samples examining PDL1 and DLL3 expression in relation to clinical characteristics and survival in small cell lung cancer.
Relevance to research design: Connects tissue biomarkers with clinical observations and questions for further validation.
Lung cancer · biomarkers · immunohistochemistry · clinical associations
Read the publication · DOI 10.1016/j.heliyon.2024.e272082023Oral drug delivery platforms for biomedical applicationsFounders among the authors: Alexey V. Yaremenko
A broad assessment of oral delivery platforms, gastrointestinal barriers and formulation requirements for small molecules and biologics.
Relevance to research design: Connects product design with the biological constraints of the oral route.
Oral delivery · gastrointestinal barriers · formulation
Read the publication · DOI 10.1016/j.mattod.2023.01.0022023Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospectsFounders among the authors: Alexey V. Yaremenko
Examines the gap between promising preclinical nanomedicines and clinical application, identifying biological and development challenges that shape translational research.
Relevance to research design: Helps define which preclinical questions matter for subsequent development.
Cancer nanomedicine · biological barriers · clinical translation
2023 journal issue; first published online in December 2022.
Read the publication · DOI 10.1016/j.medj.2022.12.0012022Influence of magnetic nanoparticle biotransformation on contrasting efficiency and iron metabolismFounders among the authors: Alexey V. Yaremenko · Nadezhda A. Pechnikova
A longitudinal investigation of nanoparticle distribution, degradation, MRI performance and iron-related biological responses.
Relevance to research design: Connects material transformation with imaging behaviour and organism-level effects.
MRI · magnetic measurements · histology · iron metabolism
Read the publication · DOI 10.1186/s12951-022-01742-w2022The marriage of Xenes and hydrogels: Fundamentals, applications, and outlookFounders among the authors: Alexey V. Yaremenko
Connects two-dimensional nanomaterials with hydrogel design, exploring applications in cancer therapy, wound healing, tissue engineering and biosensing.
Relevance to research design: Brings material properties and biomedical function together when considering new prototypes.
Hydrogels · two-dimensional materials · tissue engineering
Read the publication · DOI 10.1016/j.xinn.2022.1003272022Macrophage blockade using nature-inspired ferrihydrite for enhanced nanoparticle delivery to tumorFounders among the authors: Alexey V. Yaremenko
A preclinical study evaluating ferrihydrite-based macrophage blockade to prolong nanoparticle circulation and improve tumour delivery.
Relevance to research design: Examines the role of biological clearance pathways in drug-delivery performance.
Macrophages · circulation · biodistribution · tumour delivery
Read the publication · DOI 10.1016/j.ijpharm.2022.1217952021Metal-organic frameworks for simultaneous gene and small molecule delivery in vitro and in vivoFounders among the authors: Alexey V. Yaremenko
An experimental investigation of metal–organic frameworks as carriers for the simultaneous delivery of genetic and small-molecule cargo.
Relevance to research design: Connects material design with functional delivery in cell and animal systems.
MOFs · gene delivery · combined payloads
Read the publication · DOI 10.1016/j.cej.2021.1293862021Long-Term Fate of Magnetic Particles in Mice: A Comprehensive StudyFounders among the authors: Alexey V. Yaremenko
A longitudinal study tracking the distribution, persistence and degradation of magnetic particles in mice over an extended observation period.
Relevance to research design: Shows why particle fate and longer-term responses matter beyond initial delivery.
Biodistribution · particle degradation · longitudinal evaluation
Read the publication · DOI 10.1021/acsnano.1c006872021Efficacy of a complex medicinal herbal drug in the modeling of oxalate nephro-lithiasis in ratsFounders among the authors: Nadezhda A. Pechnikova
A comparative preclinical efficacy study in a rat model of oxalate nephrolithiasis, combining biochemical, urinary and tissue-level assessment.
Relevance to research design: Links a disease model with complementary functional and morphological endpoints for treatment evaluation.
Nephrolithiasis · preclinical efficacy · biochemistry · histology
Read the publication · DOI 10.17238/issn2072-2419.2021.1.812020Fast processes of nanoparticle blood clearance: Comprehensive studyFounders among the authors: Alexey V. Yaremenko
A systematic study of the factors that influence nanoparticle clearance from the bloodstream shortly after administration.
Relevance to research design: Informs sampling strategy and the interpretation of early circulation profiles.
Pharmacokinetics · blood clearance · quantitative analysis
Read the publication · DOI 10.1016/j.jconrel.2020.07.0142019Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growthFounders among the authors: Alexey V. Yaremenko
An experimental study of red-blood-cell-assisted nanoparticle delivery to the lungs and its evaluation in a melanoma lung-metastasis model.
Relevance to research design: Links carrier design, organ distribution and disease-relevant efficacy.
RBC hitchhiking · lung delivery · metastatic cancer
Read the publication · DOI 10.1039/c8nr07730d2019Magnetometry based method for investigation of nanoparticle clearance from circulation in a liver perfusion modelFounders among the authors: Alexey V. Yaremenko
Introduces real-time magnetic measurement of nanoparticle uptake in an isolated perfused liver, enabling focused investigation of hepatic clearance mechanisms.
Relevance to research design: Connects quantitative detection with organ-specific questions about nanoparticle clearance.
Liver perfusion · magnetometry · hepatic clearance · ex vivo
2019 journal issue; first published online in December 2018.
Read the publication · DOI 10.1088/1361-6528/aafa3a2019Methods of Visualization and Analysis of The Microcirculatory State in Veterinary and Experimental PracticesFounders among the authors: Nadezhda A. Pechnikova
A methodological overview of microvascular imaging and blood-flow assessment, supporting the selection and interpretation of endpoints in experimental research.
Relevance to research design: Helps relate a microcirculatory question to appropriate imaging and functional measurement techniques.
Microcirculation · vascular imaging · blood-flow analysis
Read the publication · DOI 10.29296/2618723X-2019-02-072018Nicotinamide riboside has protective effects in a rat model of mesenteric ischaemia-reperfusionFounders among the authors: Nadezhda A. Pechnikova
An experimental evaluation of nicotinamide riboside in a rat model of mesenteric ischaemia–reperfusion, examining microcirculation and tissue injury.
Relevance to research design: Connects a biological hypothesis with functional and tissue-level endpoints.
Rat disease model · microcirculation · tissue injury
2018 journal issue; first published online in February 2019.
Read the publication · DOI 10.1111/iep.123022018ZAIS-based colloidal QDs as fluorescent labels for theranostics: physical properties, biodistribution and biocompatibilityFounders among the authors: Nadezhda A. Pechnikova
An experimental investigation of fluorescent quantum dots, their physical properties, distribution and biocompatibility in a rat study.
Relevance to research design: Connects nanomaterial characterisation with organ distribution and preclinical tolerability measurements.
Quantum dots · biodistribution · biocompatibility · rat study
Read the publication · DOI 10.24075/brsmu.2018.0732018Hemocompatibility of magnetic magnethite nanoparticles and magnetite-silica composites in vitroFounders among the authors: Nadezhda A. Pechnikova
Experimental assessment of magnetic nanoparticle interactions with human blood, including haemolysis, erythrocyte aggregation, oxidative responses and protein adsorption.
Relevance to research design: Connects nanoparticle properties with blood-contact compatibility and concentration-dependent biological responses.
Haemocompatibility · haemolysis · erythrocyte aggregation · protein corona
Read the publication · DOI 10.20538/1682-0363-2018-3-157-1672018Investigation of the influence of endothelioprotective drug Unifuzol on the functional state of endothelium and microcirculation in experimentFounders among the authors: Nadezhda A. Pechnikova
Evaluates vascular function and regional blood flow in experimental intestinal ischaemia–reperfusion, combining wire myography with microcirculatory endpoints.
Relevance to research design: Connects experimental pharmacology with endothelial function, organ perfusion and tissue-injury models.
Vascular reactivity · ex vivo myography · microcirculation · ischaemia–reperfusion
Read the publication · DOI 10.30906/0869-2092-2018-81-5-7-112018Research of the peculiarities of colloidal quantum dots of AgInS2/ZnS and chitosan nanoparticles labeled with indocyanine green as the fluorescent labels for biomedical applicationsFounders among the authors: Nadezhda A. Pechnikova
Compares fluorescent quantum dots and labelled chitosan nanoparticles for biomedical imaging, linking material properties with performance in laboratory and animal studies.
Relevance to research design: Supports the choice and interpretation of fluorescent tracers when investigating nanoparticle behaviour in biological systems.
Quantum dots · chitosan nanoparticles · fluorescence · biomedical imaging
Read the publication · DOI 10.24884/1682-6655-2018-17-1-74-822016The dynamics of the natural biodistribution of magnetic nanoparticles synthesized in various ways, when a single infusion to Wistar ratsFounders among the authors: Nadezhda A. Pechnikova
An experimental comparison of how magnetic nanoparticle composition and synthesis influence organ distribution after intravenous administration in Wistar rats.
Relevance to research design: Connects material preparation with distribution across organs and the interpretation of preclinical exposure.
Magnetic nanoparticles · organ distribution · Wistar rats
Translational Medicine, 2016;3(4):56–65. Full text is available in the journal issue archive.
Read the publication · Journal archive2016Central hemodynamics and organ microcirculation in various organs of rats at single intravenous magnetic nanoparticles injectionFounders among the authors: Nadezhda A. Pechnikova
Assesses how magnetic nanomaterials affect systemic haemodynamics and organ perfusion, combining cardiovascular monitoring with laser Doppler measurements in a rat model.
Relevance to research design: Connects nanomaterial exposure with cardiovascular and organ-level functional responses.
Magnetic nanoparticles · haemodynamics · laser Doppler flowmetry · organ perfusion
Translational Medicine, 2016;3(4):72–81. Full text is available in the journal issue archive.
Read the publication · Journal archiveNo publications match these filters. Try a broader term or reset the filters.
Publication years follow the journal issue where available. Impact Factors link to journal, publisher or society sources, with reporting years shown when supplied. Values were checked on 14 November 2026 and are displayed where a current figure could be verified. Founder profiles link to broader publication records.
A clear route from question to interpretation
Good research begins with the decision it needs to support. We define the question, design the comparison and make the interpretation useful.
Define the decision
Review the scientific rationale and existing evidence. Agree the hypothesis, comparators, endpoints and criteria for interpreting the findings.
Build the study
Select informative models and analytical methods. Address feasibility, controls, sample-size rationale, ethics and practical constraints.
Evaluate the evidence
Use the agreed analysis plan, appropriate quality checks and transparent reporting of variability, exclusions and limitations.
Plan the next step
Integrate the results across readouts. Explain what they support, what remains uncertain and which experiment would be most informative next.
A reviewable evidence package. Depending on the agreed scope, deliverables can include a study report, methods, data files, analysis outputs, figures and recommendations. Randomisation, blinded assessment and prespecified analyses are incorporated where appropriate. Any regulatory or quality-standard requirements are defined before the study begins.
Two ways to bring the science forward
A focused experiment, an integrated work package or a broader research programme: the scope follows your objective.
For industry
Generate evidence that supports a development decision and can be reviewed by your scientific team, collaborators or prospective partners.
- Compare formulations, delivery systems or candidate products.
- Investigate mechanism, tissue exposure and biological activity.
- Connect efficacy, tolerability and material behaviour.
- Define the next preclinical milestone and the evidence it requires.
Agreed at the outset: scope, deliverables, confidentiality, data access, intended use and communication milestones.
Explore contract research servicesFor academic teams
Add complementary expertise to a study, strengthen an interdisciplinary work package or develop a complete research project with our team.
- Refine the hypothesis, experimental design and choice of models.
- Connect materials science with cellular and animal evaluation.
- Integrate results, prepare figures and strengthen interpretation.
- Develop a manuscript or address new questions raised by reviewers.
Flexible contribution: from a single scientific task to coordinated research and publication support.
See manuscript and publication supportSupport at every stage of publication
Our experience in international academic publishing can become part of your project. We support complete manuscripts or individual sections, including work intended for high-impact international journals.
Develop the scientific story
Review the evidence, identify gaps and build a coherent account of the question, methods, results and significance.
Write and visualise
Draft or revise any manuscript section, prepare publication figures and improve clarity, structure and scientific language.
Prepare the submission
Support journal selection, formatting, cover letters and submission materials, with submission coordination as agreed with the authors.
Respond and revise
Help address editorial decisions and reviewer comments, revise the manuscript and organise additional analyses where needed.
Helping evidence move towards practical application
In a rapidly expanding scientific literature, even valuable findings can be overlooked or difficult to assess. A rigorous, clearly written publication makes the question, methods, results and limitations accessible to the people who can build on them.
Publication is part of the path from a scientific idea and its experimental confirmation to practical use. Clear evidence helps other researchers evaluate and reproduce a finding, gives potential partners a basis for collaboration and helps funders understand what the next stage of development could achieve. Reaching the right scientific and clinical audiences can therefore increase a project’s chances of attracting the expertise, partnerships and resources needed to advance.
Our aim is to help promising work move along that path: from a well-designed study to credible published evidence, and from that evidence towards further development and, where relevant, clinical translation. Journal selection follows the strength of the data, scientific fit and the audience most able to act on the findings.
Co-authorship is not a condition of our support. Credit follows the contributions made; where appropriate, acknowledging Elpida BioPharm is sufficient. We can work with your team from an early draft through submission and revision. Authors retain responsibility for the scientific content and submission decisions; acceptance remains the journal’s decision.
Before we collaborate
A few practical points about evidence, scope and scientific credit.
Can you help with a topic outside these publications?
Yes. These papers illustrate our core experience, rather than define a closed list of services. We review the scientific question, required methods and practical feasibility before proposing a scope. Relevant specialist input and study-site requirements are agreed during planning.
Can a project stay confidential?
We can discuss the initial brief without disclosing sensitive details. Confidentiality, permitted use of data, intellectual property and any publication plans are agreed before the work begins. Commissioning research does not require public disclosure or publication of the results.
Can you support just one experiment or one manuscript section?
Yes. We can contribute to a defined experiment, an analysis, a figure, a manuscript section or a response to reviewers. We can also help coordinate a broader study from research design to reporting and publication preparation.
Were all these studies performed by Elpida BioPharm?
The portfolio includes work by our founders with academic and research collaborators, including publications that predate the company. It demonstrates the team’s experience. The original articles provide the full authorship, affiliations, funding and contribution statements for each study.
What should we share for an initial discussion?
A short, non-confidential description of the scientific question, the candidate or material, available evidence, the decision you need to make and your intended timeline. We can then identify the information needed to define a useful study and its deliverables.
What does your next study need to establish?
Bring us the question. We will help define the evidence, the research plan and the path forward.